Skip to main content

KAZANO

NDC 64764-335 · Takeda Pharmaceuticals America, Inc.

Generic namealogliptin and metformin hydrochloride
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)ALOGLIPTIN BENZOATE, METFORMIN HYDROCHLORIDE
Strength12.5; 500 mg/1; mg/1
Pharmacologic classBiguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]
Marketing categoryNDA

Packages

64764-335-01 — 4 CARTON in 1 TRAY (64764-335-01) / 1 BLISTER PACK in 1 CARTON / 14 TABLET, FILM COATED in 1 BLISTER PACK

64764-335-60 — 60 TABLET, FILM COATED in 1 BOTTLE (64764-335-60)

64764-335-77 — 500 TABLET, FILM COATED in 1 BOTTLE (64764-335-77)

64764-335-80 — 180 TABLET, FILM COATED in 1 BOTTLE (64764-335-80)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

63629-8503 — METFORMIN HYDROCHLORIDE, 63629-8504 — METFORMIN HYDROCHLORIDE, 63629-9147 — METFORMIN HYDROCHLORIDE, 64764-123 — alogliptin and pioglitazone, 64764-125 — alogliptin, 64764-158 — pioglitazone and metformin hydrochloride, 64764-250 — alogliptin, 64764-251 — alogliptin and pioglitazone, 64764-253 — alogliptin and pioglitazone, 64764-254 — alogliptin and pioglitazone, 64764-337 — alogliptin and metformin hydrochloride, 64764-625 — alogliptin, 65162-178 — Metformin Hydrochloride, 65162-179 — Metformin Hydrochloride, 65841-027 — METFORMIN HYDROCHLORIDE, 65841-039 — METFORMIN HYDROCHLORIDE, 65841-659 — Glipizide and Metformin Hydrochloride, 65841-660 — Glipizide and Metformin Hydrochloride, 65841-661 — Glipizide and Metformin Hydrochloride, 65841-809 — METFORMIN HYDROCHLORIDE, +618 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels